Genome Editing/Genome Engineering Market

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022

Report Code: BT 3380 Nov, 2017, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the Genome Editing/Genome Engineering Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Genome Editing/Genome Engineering Market

Request Now

[164 Pages Report] MarketsandMarkets forecasts the genome editing, genome engineering market to grow from USD 3.19 billion in 2017 to USD 6.28 billion by 2022, at a compounded annual growth rate (CAGR) of 14.5% during the forecast period. The key factors propelling market growth are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified (GM) crops, and growing application areas of genomics. The objective of the report is to define, describe, and forecast the genome editing, genome engineering market size based on technology, application, end user and region.

Genome Editing Market, by Region, 2022 (USD Billion)

By technology, CRISPR segment to account for the largest share of the global genome editing market in 2017

Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. The CRISPR segment is expected to account for the largest share of the global genome editing market, by technology. This segment is also expected to register the highest CAGR during the forecast period.

By Application, the cell line engineering segment to account for the largest share of the global genome editing market in 2017

Based on application, the market is segmented into cell line engineering, genetic engineering, and other applications. The cell line engineering segment is expected to account for the largest share of the global genome editing market, by application. Several factors such as increasing funding from governments and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving growth of the cell line engineering segment

By end user, the biotechnology and pharmaceutical companies’ segment to account the largest share of the global genome editing market

Based on end user, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs). The biotechnology and pharmaceutical companies’ segment is expected to account for the largest share of the global genome editing market, by end user.  The increasing prevalence of infectious diseases and cancer are driving research activities worldwide. This is expected to drive demand for genome editing in biotechnology & pharmaceutical companies

Genome Editing Market, by Region, 2022 (USD Billion)

North America to account for the largest market size in 2017

The North American region is leading the global genome editing market is expected to account for the largest share of the market in 2017. Factors such as the development of gene therapy in the US, increasing use of GM crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.

Asia Pacific market is projected to grow at the highest CAGR during the forecast period. In Asia Pacific, China is a mature market for genome editing, whereas Japan and India are emerging markets. Emerging Asian economies are expected to be the focal points for growth of the genome engineering market in these regions.

Market Dynamics

Driver:  Growing application areas of genomics

Although the identification of human genetic disorders and drug discovery are the major application areas of genomics, other applications of genomics technologies in agriculture, veterinary sciences, and forensics, among other fields, has increased in recent years.

The application of genomics in forensic studies has increased significantly with the advent of next-generation sequencing. This is because NGS allows at-scene analysis and extraction of more information from a trace or damaged DNA sample. Earlier, DNA analysis was used for fingerprint profiling, which is now being replaced by the genomic recreation of the complete genome. Considering the advantages offered by NGS in forensic applications, the National Institute of Justice in the US awarded a grant of USD 825,000 to the Battelle Memorial Institute in October 2014 for conducting feasibility and validation tests on a suite of new investigative tools that use next-generation sequencing in forensics.

Next-generation technologies are used in plant breeding to produce improved varieties of plants. Through genome sequencing, breeders can sequence essential traits and can produce crop varieties capable of generating more yield. Moreover, NSG can be used for DNA barcoding to identify fish larvae and eggs, along with the complete description of fish communities, during the assessment of fish populations. Similarly, genomics is increasingly being used in food quality and safety testing. This is because the genomic testing of food products can effectively identify microorganisms present in these products. Considering the potential of genomics in the food industry, market players are focusing on launching dedicated products and services for food quality and safety testing. For instance, in June 2017, Neogen (US) announced NGS services for the food industry, allowing food companies to test and identify all bacteria in a sample using a single genomic test.

Genome editing technologies play a vital role in the process of drug discovery and in the diagnosis and treatment of human genetic disorders. Genome editing is also used in NGS and DNA analysis & profiling and in plant and animal genetic engineering. Thus, with growing application areas of genomics, demand for genome editing technologies is expected to increase across the globe during the forecast period.

Restrain: Dearth of trained professionals

Genomic data can be used for various applications such as pharmacogenomics, diagnostics, and toxicogenomics. However, analysis of the large volume of data generated in genomics research is considered a major challenge. In certain cases, technological advancements have enabled the instruments in use to present an analysis; however, the interpretation still depends on the reader. Due to the high complexity involved and the need for in-depth knowledge of genomics, it is necessary to hire trained professionals to analyze and interpret the results of genomic sequencing data. However, owing to the shortage of trained professionals, a number of end users face significant challenges in analyzing genomic dat

Opportunity: Emerging Markets

Emerging markets such as Brazil, Russia, India, and China are expected to offer significant opportunities for growth of the genome editing market. This can majorly be attributed to growing R&D funding for various research organizations in these countries. For instance, R&D investment in Asia increased by 7% from 2009 to 2014. In the same period, China’s R&D investment increased by 8% (Source: Battelle)

Challenge: off-target effect of CRISPR

Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR) has emerged as an efficient technology for genome editing. The ease of use associated with the CRISPR technology is a significant advantage over ZFN and TALENs. A CRISPR/Cas9 system has good target specificity and does not require engineering of specific enzymes. However, the biggest concern regarding CRISPR/Cas9 is the issue of off-target effects. Since Cas9 induces double-stranded breaks, any off-target nuclease activity can cause mutations in genes, such as tumor suppressor genes, which can cause cancer. CRISPR/Cas9 can tolerate 1–3 mismatches in its target, which can lead to off-target nuclease activity and can further lead to unwanted chromosomal translocations. Such off-target effects of CRISPR/Cas9 are a critical challenge for the technology.

Scope of the Report

Report Metric

Details

Market size available for years

2015–2022

Base year considered

2016

Forecast period

2017–2022

Forecast units

Million (USD)

Segments covered

Technology (CRISPR, TALEN, ZFN, antisense, and other technologies), Application (Cell line engineering, genetic engineering, and other applications) and End-User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Contract Research Organizations (CROs) and Region

Geographies covered

North America, Europe, APAC, and Rest of the World

Companies covered

Thermo Fisher Scientific, Inc. (US), Merck KGaA (Merck, Germany), Genscript Biotech Corporation (US), Horizon Discovery Group plc. (UK), Lonza Group Ltd. (Switzerland), Sangamo Biosciences, Inc. (US), Integrated DNA Technologies, Inc.  (US), New England Biolabs, Inc. (US), OriGene Technologies, Inc. (US), Transposagen Biopharmaceuticals, Inc. (US), Editas Medicines (US), and CRISPR Therapeutics (Switzerland).

The research report categorizes the genome editing to forecast the revenues and analyze the trends in each of the following sub-segments:

Genome Editing Market, by Region, 2022 (USD Billion)

By Technology

  • CRISPR
  • Talen
  • ZFN
  • Antisense
  • Other Technologies

By Application

  • Cell Line Engineering
  • Genetic Engineering
    • Animal Genetic Engineering
    • Plant Genetic Engineering
  • Other Applications

By End User

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Contract Research Organization

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa

Key Market Players

The major market players in the genome editing market include Thermo Fisher Scientific, Inc. (Thermo Fisher Scientific, US) and Merck KGaA (Merck, Germany) dominated the genomics market in 2016. The other market players are Genscript Biotech Corporation (GenScript, US), Horizon Discovery Group plc. (Horizon Discovery, UK), Lonza Group Ltd. (Lonza, Switzerland), Sangamo Biosciences, Inc. (Sangamo Biosciences, US), Integrated DNA Technologies, Inc. (Integrated DNA Technologies, US), New England Biolabs, Inc. (New England Biolabs, US), OriGene Technologies, Inc. (OriGene, US), Transposagen Biopharmaceuticals, Inc. (Transposagen Biopharmaceuticals, US), Editas Medicines (Editas Medicines, US), and CRISPR Therapeutics (Switzerland).

Thermo Fisher Scientific is the leading player in the global genome editing market. The company operates in over 50 countries across North America, Europe, Asia, and Latin America. The company’s business segments include Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. The Life Sciences Solutions segment is further categorized into Biosciences, Genetic Sciences and Next-generation Sequencing, and BioProduction. The Genetic Sciences segment offers a variety of instruments and reagents used for the analysis of DNA that has applications in research and clinical purposes. Moreover, the company invests in R&D activities to increase its depth of capabilities in technologies, software, and services.

Recent Developments

  • In 2019, Merck signed a license agreement with Evotec SE. This agreement will enable Evotec access to Merck’s foundational CRISPR intellectual property.
  • In 2018, Thermo Fisher Scientific, Inc. expanded its Genome Editing IP Portfolio
  • In 2018, Horizon Discovery launched Edit-R CRISPRa arrayed crRNA (CRISPR RNA) libraries, an addition to its CRISPR activation (CRISPRa) reagent platform.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the genome editing market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
    2.3 Market Data Validation and Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 Genome Editing: Market Overview
    4.2 Europe: Genome Editing Market, By Application
    4.3 Genome Editing Market, By End User
    4.4 Genome Editing Market, By Country/Region

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                    5.2.1.2 Growing Application Areas of Genomics
                    5.2.1.3 High Prevalence of Infectious Diseases and Cancer
                    5.2.1.4 Technological Advancements
                    5.2.1.5 Increasing Production of Genetically Modified Crops
           5.2.2 Restraints
                    5.2.2.1 Dearth of Trained Professionals
                    5.2.2.2 Adverse Public Perception of Genetic Research
           5.2.3 Opportunities
                    5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
                    5.2.3.2 Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 High Cost of Genomics Equipment
                    5.2.4.2 Off-Target Effect of Crispr
                    5.2.4.3 Secure Storage of Large Volumes of Sequenced Data

6 Genome Engineering Market, By Technology (Page No. - 43)
    6.1 Introduction
    6.2 Crispr
    6.3 Talen
    6.4 ZFN
    6.5 Antisense
    6.6 Other Technologies

7 Genome Engineering Market, By Application (Page No. - 51)
    7.1 Introduction
    7.2 Cell Line Engineering
    7.3 Genetic Engineering
           7.3.1 Animal Genetic Engineering
           7.3.2 Plant Genetic Engineering
    7.4 Other Applications

8 Genome Engineering Market, By End User (Page No. - 60)
    8.1 Introduction
    8.2 Biotechnology & Pharmaceutical Companies
    8.3 Academic & Government Research Institutes
    8.4 Contract Research Organizations

9 Genome Engineering Market, By Region (Page No. - 65)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 Research Grants and Funding By Government Institutes
                    9.2.1.2 Increasing Use of Gm Crops
                    9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the US
                    9.2.1.4 Genome Editing Conferences in the US
                    9.2.1.5 Increasing Prevalence of Cancer
                    9.2.1.6 Strategic Developments in the US Market
           9.2.2 Canada
                    9.2.2.1 Availability of Research Funding in Canada
                    9.2.2.2 Rising Incidence of Cancer
                    9.2.2.3 Gapp to Intensify Genomic R&D
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Presence of A Large Number of Academic Institutes
                    9.3.1.2 Availability of Funding for Life Science Research
                    9.3.1.3 Conferences/Meetings/Symposiums/Workshops in Germany
           9.3.2 UK
                    9.3.2.1 Increasing Funds and Grants By Government Bodies
                    9.3.2.2 100,000 Genomes Project in the UK
           9.3.3 France
                    9.3.3.1 Increasing Government Investments in Genomics
                    9.3.3.2 Introduction of Noninvasive Prenatal Testing in France
           9.3.4 RoE
                    9.3.4.1 Spain’s Focus on Research
                    9.3.4.2 Growth in the Italian Biotech and Pharma Sectors
                    9.3.4.3 Growing Research Investments in Sweden & Denmark
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 Government Initiatives to Support Healthcare Research in China
                    9.4.1.2 Efforts of BGI to Boost the Genomics Market in China
                    9.4.1.3 High Intensity of R&D Activities in China
           9.4.2 Japan
                    9.4.2.1 Increasing Government Focus on Cancer Research
                    9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
                    9.4.2.3 Focus on Cancer Research and Treatment
           9.4.3 India
                    9.4.3.1 Emergence of Local Players in India Backed By Government Funding
                    9.4.3.2 Increasing Support for Biotech Start-UPS
                    9.4.3.3 Growth of the Pharmaceutical Industry in India
           9.4.4 RoAPAC
                    9.4.4.1 Alliances and Partnerships in the Australian Market
                    9.4.4.2 Genome Asia 100k Initiative
                    9.4.4.3 Crop Research Initiatives in Asia
    9.5 RoW
           9.5.1 Latin America
                    9.5.1.1 Alliances, Availability of Government Funding in Brazil
                    9.5.1.2 Conferences & Workshops in Brazil (2016-2017)
           9.5.2 Middle East and Africa
                    9.5.2.1 Genetic Testing and Genomic Analysis in the Middle East
                    9.5.2.2 Rising Prevalence of HIV and Cancer in Africa

10 Competitive Landscape (Page No. - 117)
     10.1 Key Developments By Leading Players in the Genome Editing Market (2014-2017)
     10.2 Market Share Analysis
             10.2.1 Thermo Fisher Scientific
             10.2.2 Merck
             10.2.3 Horizon Discovery Group
     10.3 Competitive Scenario
             10.3.1 Agreements, Collaborations, and Partnerships
             10.3.2 Product & Service Launches, By Company
             10.3.3 Acquisitions
             10.3.4 Expansions

11 Company Profiles (Page No. - 125)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
     11.1 Thermo Fisher Scientific
     11.2 Merck
     11.3 Horizon Discovery Group
     11.4 Genscript
     11.5 Sangamo Biosciences
     11.6 Integrated Dna Technologies
     11.7 Lonza
     11.8 New England Biolabs
     11.9 Origene Technologies
     11.10 Transposagen Biopharmaceuticals
     11.11 Editas Medicine
     11.12 Crispr Therapeutics

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 156)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (96 Tables)

Table 1 Global Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 2 Crispr-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 3 Talen-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 4 ZFN-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 5 Antisense-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 6 Genome Editing Market for Other Technologies, By Country/Region, 2015–2022 (USD Million)
Table 7 Global Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 8 Genome Engineering Market for Cell Line Engineering, By Country, 2015–2022 (USD Million)
Table 9 Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 10 Genome Engineering Market for Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 11 Genome Engineering Market for Animal Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 12 Genome Engineering Market for Plant Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 13 Genome Engineering Market for Other Applications, By Country, 2015–2022 (USD Million)
Table 14 Global Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 15 Genome Engineering Market for Biotechnology & Pharmaceutical Companies, By Region, 2015–2022 (USD Million)
Table 16 Genome Engineering Market for Academic & Government Research Institutes, By Region, 2015–2022 (USD Million)
Table 17 Genome Engineering Market for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 18 Genome Engineering Market, By Region, 2015–2022 (USD Million)
Table 19 Genome Engineering Market, By Country/Region, 2015–2022 (USD Million)
Table 20 North America: Genome Engineering Market, By Country, 2015–2022 (USD Million)
Table 21 North America: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 22 North America: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 23 North America: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 24 North America: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 25 US: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 26 US: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 27 US: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 28 US: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 29 Indicative List of Projects Funded By Gapp in 2014
Table 30 Canada: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 31 Canada: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 32 Canada: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 33 Canada: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 34 Conference, Meeting, Course and Workshop in Europe (2014-2018)
Table 35 Europe: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 37 Europe: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 38 Europe: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 39 Europe: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 40 Conferences, Meetings, Symposiums, Workshops in Germany (2014-2018)
Table 41 Germany: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 42 Germany: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 43 Germany: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 44 Germany: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 45 UK: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 46 UK: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 47 UK: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 48 UK: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 49 France: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 50 France: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 51 France: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 52 France: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 53 RoE: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 54 RoE: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 55 RoE: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 56 France: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 57 Asia Pacific: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 58 Asia Pacific: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 59 Asia Pacific: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 60 Asia Pacific: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 61 Asia Pacific: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 62 China: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 63 China: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 64 China: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 65 China: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 66 Conferences, Symposia, & Workshops in Japan, 2016-2018
Table 67 Japan: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 68 Japan: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 69 Japan: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 70 Japan: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 71 India: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 72 India: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 73 India: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 74 Europe: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 75 RoAPAC: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 76 RoAPAC: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 77 RoAPAC: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 78 RoAPAC: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 79 RoW: Genome Editing Market, By Region, 2015–2022 (USD Million)
Table 80 RoW: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 81 RoW: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 82 RoW: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 83 RoW: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 84 Latam: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 85 Latam: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 86 Latam: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 87 Latam: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 88 HIV Infections and Aids-Related Deaths in the Middle East and Africa, 2014
Table 89 MEA: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 90 MEA: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 91 MEA: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 92 MEA: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 93 Agreements, Collaborations, and Partnerships, By Company (2015–2017)
Table 94 Product & Service Launches, By Company (2015–2017)
Table 95 Acquisitions, By Company (2015–2017)
Table 96 Expansions, By Company (2015–2017)


List of Figures (42 Figures)

Figure 1 Global Genome Editing Market Segmentation
Figure 2 Global Genome Editing Market: Research Methodology Steps
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Global Genome Editing Market, By Technology (2017–2022)
Figure 9 Global Genome Editing Market, By Application, 2017 vs 2022 (USD Million)
Figure 10 Global Genome Editing Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Geographical Snapshot of the Genome Editing Market
Figure 12 Rising Government Funding and High Prevalence of Infectious Diseases & Cancer—Key Growth Drivers of the Genome Editing Market
Figure 13 Cell Line Engineering Segment to Account for the Largest Market Share in 2017
Figure 14 Biotechnology & Pharmaceutical Companies Will Continue to Dominate the Genome Editing Market in 2022
Figure 15 North America to Register the Highest CAGR in the Forecast Period
Figure 16 Genome Editing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Global Genome Editing Market, By Technology, 2017 vs 2022 (USD Million)
Figure 18 Global Genome Editing Market, By Application, 2017 vs 2022 (USD Million)
Figure 19 Genome Editing Market for Genetic Engineering, By Type, 2017 vs 2022 (USD Million)
Figure 20 Genome Editing Market, By End User, 2017 vs 2022 (USD Million)
Figure 21 Genome Editing Market, By Region, 2017 vs 2022 (USD Million)
Figure 22 North America: Genome Editing Market Snapshot
Figure 23 North Amarica: Number of New Cancer Cases, By Country
Figure 24 Prevalence of Alzheimer's Disease in the US, By Age (2016)
Figure 25 Europe: Genome Editing Market Snapshot
Figure 26 Europe: Number of New Cancer Cases, By Country
Figure 27 Asia Pacific: Genome Editing Market Snapshot
Figure 28 APAC: Number of New Cancer Cases, By Type
Figure 29 RoW: Genome Editing Market Snapshot
Figure 30 Market Share Analysis, By Key Player, 2016
Figure 31 Agreements, Collaborations, and Partnerships—Key Growth Strategy Adopted By Market Players
Figure 32 Agreements, Collaborations, and Partnerships, By Company (2014–2017)
Figure 33 Product & Service Launches, By Company (2014-2017)
Figure 34 Acquisitions, By Company (2014–2017)
Figure 35 Expansions, By Company (2014–2017)
Figure 36 Thermo Fisher Scientific: Company Snapshot
Figure 37 Merck: Company Snapshot
Figure 38 Horizon Discovery: Company Snapshot
Figure 39 Genscript : Company Snapshot
Figure 40 Sangamo Biosciences: Company Snapshot
Figure 41 Lonza: Company Snapshot
Figure 42 Editas Medicine: Company Snapshot

To get more details on this report, Request FREE Sample


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 3380
Published ON
Nov, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Genome Editing/Genome Engineering Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home